Endoscopic retrograde cholangiopancreatography‐obtained bile culture in acute cholangitis: retrospective analysis of bile cultures and risk factors in a tertiary care center
Petros Stathopoulos,Paulina Lerner,Philipp Astheimer,Lutz P. Breitling,Malte Zumblick,Michael Pararas,Michael Lohoff,Thomas M. Gress,Ulrike W. Denzer
DOI: https://doi.org/10.1111/jgh.16492
2024-01-26
Journal of Gastroenterology and Hepatology
Abstract:Background Collection of bile aspirate during endoscopic retrograde cholangiopancreatography (ERCP) is essential to identify pathogens responsible for acute cholangitis. Limited data are available on the risk factors for the presence of multidrug‐resistant organisms (MDRO) in bile. Methods We conducted this retrospective, single‐center study to assess the prevalence and susceptibility rates of bacteria in bile cultures, and the risk factors for the presence of pathogens, MDRO, and fungi in bile. All consecutive patients who underwent biliary drainage for acute cholangitis from January 2017 to December 2019 were included. Results 443/1610 ERCPs were performed for acute cholangitis. Bile culture was collected in 91.4% (405/443), of which 86.7% were positive. Most common isolates were Enterococcus faecalis (37.6%) and Escherichia coli (32.8%). Vancomycin resistance was found in 9.9% of Enterococcus species (spp.); extended‐spectrum beta‐lactamases (ESBL) and carbapenemases in 11.2% and 0.9% of Enterobacteriaceae, respectively. The empiric antimicrobial therapy was changed in 26.4% (n = 107) of cases, with a clinical response in 90.7%. In multivariate analysis, biliary stenting was an independent risk factor for positive bile culture (odds ratio [OR] 9.43; P 60 years (OR 2.51; P = 0.03), previous sphincterotomy (OR 2.57; P = 0.02), and biliary stenting (OR 2.80; P
gastroenterology & hepatology